⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
PhenoAge (Phenotypic Age)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-01 — A phenotype-based ageing clock that reflects development rather than senescence in a wild mammal.: [animal-model] Observational study in wild Soay sheep found that a morphology-based phenotypic clock reflected developmental rate rather than senescence, with positive age deviation predicting greater over-winter survival; this is not the human clinical-lab PhenoAge or DNAm PhenoAge algorithm and does not revise their human validation evidence. [animal-model] (novelty: 3)
- 2026-10-07 — Plasma proteomic signatures of biological aging and metabolic dysfunction-associated steatotic liver disease risk: a prospective cohort study.: UK Biobank prospective cohort: PhenoAge was among four biological-age metrics whose association with incident MASLD was partially mediated by a shared five-protein plasma core (AXL, CCL19, CPM, REN, TNFRSF11B) — incremental support for PhenoAge sensitivity to a hepatic steatotic disease endpoint via immune-inflammatory proteomic pathways, association plus mediation only. [human-observational] (novelty: 3)
- 2026-05-25 — Exposure to size-specific particulate matter accelerates DNA methylation aging in people with HIV.: Observational study in people with HIV reports short-term size-specific PM exposure (especially PM10) associated with PhenoAge acceleration alongside other DNAm clocks — incremental support that PhenoAge is sensitive to short-term ambient particulate exposure in a high-vulnerability clinical population, association only. [human-observational] (novelty: 3)
- 2026-07-12 — Blood Biochemistry Age Clock - An interpretable estimate of biological age and predictor of all-cause-mortality derived from routinely ordered blood biomarkers.: Head-to-head benchmark in UK Biobank and NHANES: an 11-marker Blood Biochemistry Age Clock (BBAC) built from routine bloods matched PhenoAge on all-cause mortality and eight chronic-disease incidence endpoints, with an optimized BBAC variant outperforming PhenoAge on AIC — incremental evidence that PhenoAge is beatable by a simpler, interpretable routine-labs clock. [human-observational] (novelty: 3)
- 2026-07-16 — Clonal haematopoiesis of indeterminate potential and epigenetic age acceleration: Systematic review and meta-analysis.: Included in a systematic review and meta-analysis (~7,000 adults) of CHIP–epigenetic-age associations: PhenoAge acceleration was elevated in CHIP carriers across pooled studies, with TET2-mutated and larger clones carrying the strongest signal — incremental evidence that PhenoAge tracks clonal hematopoiesis burden, observational. [human-observational] (novelty: 3)
- 2026-10-01 — Neighborhood poverty duration, timing, and severity from adolescence to early midlife and biological aging.: Same 25-year US longitudinal cohort: PhenoAge acceleration tracked cumulative life stages of neighborhood poverty exposure with mid-adulthood exposure strongest — incremental support that PhenoAge is sensitive to duration/timing/severity of neighborhood-level socioeconomic exposure, association only. [human-observational] (novelty: 3)
- 2026-07-27 — Residential context and epigenetic age acceleration among older-age black and white Americans: Findings from the health and retirement study, 2010-2016.: Same HRS multigroup SEM analysis: PhenoAge acceleration in 2016 was lower among older White adults who in 2010 lived in predominantly White, higher-income neighborhoods, with income partially mediating the effect; no comparable association in Black participants — incremental support that PhenoAge tracks residential-context exposures in a race-stratified manner, association only. [human-observational] (novelty: 3)
- 2026-08-14 — Identifying biomarkers of accelerated ageing in cancer patients from routine clinical data.: Geriatric oncology cohort study: PhenoAgeAccel computed from routine bloods outperformed chronological age for predicting one-year mortality and frailty in older cancer patients, with higher acceleration observed after systemic anti-cancer treatment — extends PhenoAge to a cancer-geriatrics stratification use case and offers a pre/post-treatment acceleration signal, association only without causal attribution of clock movement to treatment toxicity. [human-observational] (novelty: 3)
- 2026-08-21 — Examination of DNAm PhenoAge as an epigenetic biomarker for perioperative risk in adult spinal deformity surgeries.: Multicenter adult spinal deformity surgery registry: DNAm PhenoAge associated with several postoperative adverse events and consistently improved model fit and reclassification over chronological age, though AUC gains were not statistically significant — extends PhenoAge to a second surgical-outcome context (after TKA) with honest reporting that discrimination improvement is directional, not confirmed. [human-observational] (novelty: 3)
- 2026-08-22 — Ensemble DNA methylation clock demonstrates Immune-metabolic aging signatures associated with mortality.: Head-to-head benchmark in Framingham found a 190-CpG stacked ensemble DNAm survival clock outperformed PhenoAge for all-cause mortality prediction (and matched GrimAge), incremental evidence that PhenoAge is beatable by ensemble DNAm survival models. [human-observational] (novelty: 3)
- 2026-08-22 — Neighborhood amenities, health services, and built infrastructure and epigenetic aging.: HRS neighborhood-resources analysis: built-infrastructure index indirectly associated with slower PhenoAge via higher physical activity, not through a direct neighborhood–PhenoAge link — incremental mediation evidence that PhenoAge tracks activity-mediated neighborhood exposures rather than resource availability per se. [human-observational] (novelty: 3)
- 2026-10-05 — Accelerated Biological Aging and Risk of Early-Onset Colorectal Cancer: Findings from a Large Prospective East Asian Cohort.: Prospective Korean cohort (~200,000 adults <50): PhenoAge acceleration independently associated with ~93% higher risk of early-onset colorectal adenocarcinoma but not neuroendocrine tumors — extends PhenoAge outcome coverage to EOCRC with histology-specific signal in an East Asian population, association only. [human-observational] (novelty: 3)
- 2026-10-06 — Association of systemic aging and frailty with retinal alterations: insights from an integrated exposome and metabolome framework.: UK Biobank cross-sectional analysis (>45,000 participants): PhenoAge acceleration inversely associated with macular thickness, with plasma metabolomic signatures mediating a substantial share of the association and adverse exposomes acting through aging/metabolic pathways — extends PhenoAge sensitivity to a retinal neurosensory structural endpoint, association plus mediation only. [human-observational] (novelty: 3)
- 2026-10-06 — A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study.: Same NHANES CKMAI analysis: PhenoAge was outperformed by a CKM-pathway-tailored ML index (CKMAI) for all-cause and CV mortality and high-risk CKM status — incremental head-to-head evidence that PhenoAge is beatable by domain-specific ML aging indices in cardiovascular-kidney-metabolic prediction. [human-observational] (novelty: 3)
- 2026-07-24 — Geriatric syndromes and intrinsic capacity in intestinal failure: A comparative analysis between young adults and older adults.: Comparative observational study in chronic intestinal failure: young adults with CIF showed a larger chronological–PhenoAge gap than adults ≥65 without CIF, extending PhenoAge acceleration to a new disease-specific population alongside higher malnutrition and multimorbidity burden — association only, no intervention or outcome data. [human-observational] (novelty: 3)
- 2025-12-11 — Healthy diet and slower biological aging as protective factors against microvascular complications in type 2 diabetes.: Prospective T2DM cohort: higher healthy-diet scores and lower PhenoAgeAccel were independently and jointly associated with reduced incident diabetic microvascular complications, with PhenoAgeAccel formally mediating ~30–43% of the diet–complication association — extends PhenoAge to a disease-specific microvascular endpoint and positions it as a partial mediator of a dietary exposure, association plus mediation only. [human-observational] (novelty: 3)
- 2026-09-07 — Long-term ambient benzene exposure, acceleration of biological aging, and risk of incident psychiatric disorders: A cohort study in the UK Biobank.: UK Biobank cohort analysis: long-term ambient benzene exposure associated with higher incidence of single and multiple psychiatric disorders, with PhenoAge acceleration partially mediating the exposure–psychiatric-outcome link — extends PhenoAge sensitivity to ambient air-pollutant exposures and positions it as a mediator between environmental exposure and mental-health incidence, association only. [human-observational] (novelty: 3)
- 2026-09-14 — Biological age measured by DNA methylation clocks and reproductive history: Systematic review and meta-analysis.: Same meta-analysis (29 studies, ~550k women): PhenoAge was among the second-generation clocks showing acceleration with earlier menopause and higher parity, with no consistent age-at-menarche signal — incremental support that PhenoAge tracks female reproductive-history exposures alongside GrimAge, association only. [human-observational] (novelty: 3)
- 2026-09-15 — Duration of smoking cessation and DNA methylation aging clocks among US adults: potential reversibility of smoking-induced biological aging.: Same NHANES cessation-duration analysis included PhenoAge among six clocks; PhenoAge showed a smaller/less clean dose-response to years-since-quit than GrimAge2 and DunedinPoAm, incremental evidence that PhenoAge is less sensitive to smoking-history reversibility than the GrimAge-family clocks. [human-observational] (novelty: 3)
- 2026-09-14 — Accelerated biological ageing is associated with a large drusen burden.: NHANES cross-sectional analysis: PhenoAge acceleration was associated with higher odds of large drusen burden but not pigmentary abnormalities in early AMD — extends PhenoAge sensitivity to an ocular structural aging endpoint, association only and no intervention data. [human-observational] (novelty: 3)
- 2026-09-18 — Associations of single and combined exposure to plasma metals with biological aging in Chinese adults: Mediation by inflammation and oxidative stress and moderation by diabetes.: Chinese adult cross-sectional plasma-metals mixture analysis: single and combined plasma metal exposures (especially copper, with selenium and antimony contributing) associated with accelerated PhenoAge and related biological-age metrics, partially mediated by inflammation and oxidative stress and moderated by diabetes status — extends PhenoAge sensitivity to environmental metal exposures, association only. [human-observational] (novelty: 3)
- 2026-09-23 — Periodontitis, Edentulism, and Accelerated Biological Aging: A Population-Based Study of Epigenetic Clocks.: Same NHANES analysis: PhenoAge acceleration ~1–2 years higher in adults ≥50 with severe/higher-grade periodontitis and edentulism, consistent with the other second-gen clocks tested — incremental support for PhenoAge sensitivity to oral disease burden, association only. [human-observational] (novelty: 3)
- 2026-09-26 — Exploring Epigenetic Aging and Cognitive Change in Middle Adulthood.: Same midlife cognition study (n=139) included PhenoAge among the epigenetic clocks whose age deviation was associated with lower peak cognitive performance and greater processing-speed variability across a measurement-burst protocol — incremental support that PhenoAge tracks cognitive-feature differences below traditional old-age cohorts, association only. [human-observational] (novelty: 3)
- 2026-09-12 — Association Between Iron Availability and Accelerated Biological Aging in Non-Anemic Women of Reproductive Age: A Nationally Representative Cross-Sectional Study.: NHANES cross-sectional analysis of non-anemic women aged 20–49: each unit increase in sTfR index (subclinical low iron availability without anemia) associated with ~1.9 additional years of PhenoAge acceleration — extends PhenoAge sensitivity below the clinical anemia threshold, association only and no intervention data. [human-observational] (novelty: 3)
- 2026-09-24 — The GrimAge clock corresponds to brain ageing and social determinants of health in people with HIV.: Same HIV cohort: PhenoAge acceleration present in virally suppressed PWH alongside GrimAge and DunedinPACE, though GrimAge carried the specific links to brain-age gap, cognition, and social-determinant/CVD risk — PhenoAge co-elevated but not the strongest correlate of the neurocognitive/social endpoints in this population. [human-observational] (novelty: 3)
- 2026-09-15 — Biological Age Acceleration Predicts Functional Decline and Surgical Risk in Knee Arthroplasty.: Retrospective TKA cohort: PhenoAge-style biological age acceleration from clinical bloods predicted slower postoperative gait and higher perioperative complication rates than chronological age — extends phenotypic-age validity to a surgical-outcome endpoint, but clock movement was not tested and this is association only. [human-observational] (novelty: 3)
- 2026-09-01 — Comparative mediation roles of body shape indices in the association between Healthy Eating Index-2015 and phenotypic age acceleration: A cross-sectional study based on NHANES 2005-2010.: NHANES 2005-2010 cross-sectional analysis: higher Healthy Eating Index-2015 scores were associated with lower odds of phenotypic age acceleration, with waist-to-height ratio and Body Roundness Index partially mediating the diet–PhenoAge link more strongly than BMI — association plus mediation, not causal de-aging. [human-observational] (novelty: 3)
- 2026-09-14 — GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension.: Same 2026 GLP-1 RA geroprotection review cites PhenoAge among the second-generation clocks reported to decelerate under semaglutide in the 2025 randomized trial it synthesizes — indirect (review-mediated) support that PhenoAge is responsive to GLP-1 exposure, not primary trial data on this page. [expert-opinion] (novelty: 3)
- 2026-09-09 — Childhood trauma, accelerated biological aging and chronic pain across two population cohorts: Cross-cohort analysis includes PhenoAge (second-generation) among the clocks showing acceleration in adults reporting childhood trauma and partially mediating the trauma–chronic-pain link, particularly in women — associational mediation, not causal. [human-observational] (novelty: 3)
- 2025-11-22 — Exploring the role of β2-microglobulin in the relationship between physical activity and DNAm-predicted PhenoAge: Evidence from a population-based and mice single-cell RNA-sequencing study.: NHANES-based cross-sectional analysis: higher self-reported physical activity was associated with lower DNAm-PhenoAge, with circulating β2-microglobulin statistically mediating ~38% of the association; mouse scRNA-seq linked exercise to β2M and immune–mitochondrial pathway shifts — association plus mediation, not causal de-aging. [human-observational] (novelty: 3)
- 2026-03-25 — Associations of epigenetic age acceleration with motor impairment: Evidence from the Parkinson’s Progression Markers Initiative cohort.: In the PPMI PD cohort, PhenoAge acceleration was among the clocks associated with longitudinal tremor progression, particularly in male participants — incremental support for PhenoAge tracking a disease-specific motor endpoint, association only. [human-observational] (novelty: 3)
- 2026-07-02 — Accelerated Biological Aging Increases the Risk of Head and Neck Cancer: Insights From Genetic Instruments of Epigenetic Clocks.: In the same HNSCC MR/case-control analysis of epigenetic-age-acceleration polygenic scores, PhenoAge acceleration was not the primary driver of HNSCC risk — HannumAge and GrimAge instruments carried the signal, so PhenoAge underperformed those clocks for this cancer endpoint. [human-observational] (novelty: 3)
- 2026-07-28 — Joint effects of social determinants of health on NAFLD mortality: the mediating role of phenotypic age acceleration.: NHANES cross-sectional/mortality analysis in adults with NAFLD: composite unfavorable social determinants of health showed dose-response association with all-cause and CVD mortality, with PhenoAge acceleration mediating ~11% of the all-cause mortality effect — supports PhenoAge as a partial biological mediator between social adversity and survival, not proof of causal aging. [human-observational] (novelty: 3)
Open questions
Related
Contributing findings
Routine Blood Tests Form Core of Biological Age Models, Systematic Review Finds
10-nov-2026
novelty 2
per-area 2
strengthens
A phenotype-based ageing clock that reflects development rather than senescence in a wild mammal.
01-nov-2026
novelty 3
per-area 3
strengthens
Dietary preference, biological aging, and incident dementia: a prospective cohort study.
07-oct-2026
novelty 3
per-area 2
strengthens
Plasma proteomic signatures of biological aging and metabolic dysfunction-associated steatotic liver disease risk: a prospective cohort study.
07-oct-2026
novelty 3
per-area 3
strengthens
Association of systemic aging and frailty with retinal alterations: insights from an integrated exposome and metabolome framework.
06-oct-2026
novelty 3
per-area 3
strengthens
A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study.
06-oct-2026
novelty 3
per-area 3
strengthens
Accelerated Biological Aging and Risk of Early-Onset Colorectal Cancer: Findings from a Large Prospective East Asian Cohort.
05-oct-2026
novelty 3
per-area 3
strengthens
Neighborhood poverty duration, timing, and severity from adolescence to early midlife and biological aging.
01-oct-2026
novelty 3
per-area 3
strengthens
Accelerated biological aging in the association between early-life tobacco smoke exposure and dementia risk: An exploratory mediation analysis.
29-sep-2026
novelty 2
per-area 2
strengthens
Epigenetic age acceleration is associated with brain connectivity changes and the risk of major depression after trauma
28-sep-2026
novelty 3
per-area 2
mentions
Dietary pattern and epigenetic aging: a longitudinal twin study.
26-sep-2026
novelty 3
per-area 2
mentions
Exploring Epigenetic Aging and Cognitive Change in Middle Adulthood.
26-sep-2026
novelty 3
per-area 3
strengthens
Proposing a Novel Set of Proxy Measures of Aging Rate
24-sep-2026
novelty 2
per-area 1
mentions
The GrimAge clock corresponds to brain ageing and social determinants of health in people with HIV.
24-sep-2026
novelty 3
per-area 3
strengthens
Evaluation of the Effect of Seasonality on Biological Age in Adults
23-sep-2026
novelty 2
per-area 2
mentions
Periodontitis, Edentulism, and Accelerated Biological Aging: A Population-Based Study of Epigenetic Clocks.
23-sep-2026
novelty 3
per-area 3
strengthens
Phenotypic age metrics for risk stratification of chronic disease burden and all-cause mortality in adults.
22-sep-2026
novelty 2
per-area 2
strengthens
Associations of single and combined exposure to plasma metals with biological aging in Chinese adults: Mediation by inflammation and oxidative stress and moderation by diabetes.
18-sep-2026
novelty 3
per-area 3
strengthens
Association of smoking behaviors with GOLD biological age acceleration and potential mediation: Evidence from NHANES 1999-2023.
18-sep-2026
novelty 2
per-area 1
mentions
Duration of smoking cessation and DNA methylation aging clocks among US adults: potential reversibility of smoking-induced biological aging.
15-sep-2026
novelty 3
per-area 3
strengthens
Biological Age Acceleration Predicts Functional Decline and Surgical Risk in Knee Arthroplasty.
15-sep-2026
novelty 3
per-area 3
strengthens
Biological age measured by DNA methylation clocks and reproductive history: Systematic review and meta-analysis.
14-sep-2026
novelty 3
per-area 3
strengthens
Accelerated biological ageing is associated with a large drusen burden.
14-sep-2026
novelty 3
per-area 3
strengthens
[Biological age in orthopedics : Importance, assessment, and clinical recommendations].
14-sep-2026
novelty 2
per-area 1
mentions
GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension.
14-sep-2026
novelty 3
per-area 3
strengthens
Association Between Iron Availability and Accelerated Biological Aging in Non-Anemic Women of Reproductive Age: A Nationally Representative Cross-Sectional Study.
12-sep-2026
novelty 3
per-area 3
strengthens
Epigenetic clocks and accelerated biological aging in people living with HIV: Emerging mechanisms and clinical implications.
12-sep-2026
novelty 2
per-area 2
mentions
Childhood trauma, accelerated biological aging and chronic pain across two population cohorts
09-sep-2026
novelty 3
per-area 3
strengthens
Biological Age Predicts Mortality in Cardio-Kidney-Metabolic Syndrome
08-sep-2026
novelty 2
per-area 2
mentions
Long-term ambient benzene exposure, acceleration of biological aging, and risk of incident psychiatric disorders: A cohort study in the UK Biobank.
07-sep-2026
novelty 3
per-area 3
strengthens
Stability and Predictors of Phenotypic Age Acceleration among Virally Suppressed Asians with HIV over Five Years.
03-sep-2026
novelty 2
per-area 2
strengthens
Comparative mediation roles of body shape indices in the association between Healthy Eating Index-2015 and phenotypic age acceleration: A cross-sectional study based on NHANES 2005-2010.
01-sep-2026
novelty 3
per-area 3
strengthens
Ensemble DNA methylation clock demonstrates Immune-metabolic aging signatures associated with mortality.
22-aug-2026
novelty 3
per-area 3
strengthens
Neighborhood amenities, health services, and built infrastructure and epigenetic aging.
22-aug-2026
novelty 3
per-area 3
strengthens
Examination of DNAm PhenoAge as an epigenetic biomarker for perioperative risk in adult spinal deformity surgeries.
21-aug-2026
novelty 3
per-area 3
strengthens
Identifying biomarkers of accelerated ageing in cancer patients from routine clinical data.
14-aug-2026
novelty 3
per-area 3
strengthens
Joint effects of social determinants of health on NAFLD mortality: the mediating role of phenotypic age acceleration.
28-jul-2026
novelty 3
per-area 3
strengthens
Residential context and epigenetic age acceleration among older-age black and white Americans: Findings from the health and retirement study, 2010-2016.
27-jul-2026
novelty 3
per-area 3
strengthens
Geriatric syndromes and intrinsic capacity in intestinal failure: A comparative analysis between young adults and older adults.
24-jul-2026
novelty 3
per-area 3
strengthens
Nocturia is Associated with Biological Age not Chronological Age.
23-jul-2026
novelty 2
per-area 2
strengthens
Clonal haematopoiesis of indeterminate potential and epigenetic age acceleration: Systematic review and meta-analysis.
16-jul-2026
novelty 3
per-area 3
strengthens
Blood Biochemistry Age Clock - An interpretable estimate of biological age and predictor of all-cause-mortality derived from routinely ordered blood biomarkers.
12-jul-2026
novelty 3
per-area 3
strengthens
Accelerated Biological Aging Increases the Risk of Head and Neck Cancer: Insights From Genetic Instruments of Epigenetic Clocks.
02-jul-2026
novelty 3
per-area 3
strengthens
Reframing diet assessment for geroscience: development and preliminary validation of an anti-aging dietary score.
22-jun-2026
novelty 3
per-area 2
mentions
Exposure to size-specific particulate matter accelerates DNA methylation aging in people with HIV.
25-may-2026
novelty 3
per-area 3
strengthens
Associations of epigenetic age acceleration with motor impairment: Evidence from the Parkinson's Progression Markers Initiative cohort.
25-mar-2026
novelty 3
per-area 3
strengthens
Healthy diet and slower biological aging as protective factors against microvascular complications in type 2 diabetes.
11-dec-2025
novelty 3
per-area 3
strengthens